Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Latest news

4/25/2019 Database Update: Import of Pharmaceutical Drugs Made in EEU Countries to Russia (March 2019)

Between January and March 2019, Russia imported 2.6 bln RUB worth of pharmaceuticals made in the EEU countries (wholesale prices, VAT included), which is in monetary terms 49.6% higher than that of the same period in 2018. The dynamics in physical terms are +61.2% (65.3 mln units).

4/24/2019 RNC Pharma Database Update: Pharmaceutical Drug Production in Russia (March 2019)

Between January and March 2019, Russia produced 86.9 bln RUB worth of pharmaceuticals (manufactures’ dispatch prices, VAT included), which is in monetary terms 14.7% higher than that of the same period of 2018. However, the dynamics in physical terms are only +0.5% (1.01 bln units).

4/18/2019 Database Update: Pharmaceutical Drug Export from Russia (January 2019)

In January 2019, Russia exported 1.53 bln RUB worth of pharmaceutical drugs (customs duties included, exports to the EEU countries excluded), which is in monetary terms 73.3% higher than that of January 2018. In physical terms, the dynamics are +46.4% (31.0 mln units.)

4/17/2019 Database Update: Pharmaceutical Drug Export from Russia (January 2019)

Between January and February 2019, Russia imported 9.0 bln RUB worth of veterinary products (free circulation prices, VAT included), which is in monetary terms 8.6% higher than that of the same period in 2018. Russia imported nearly 5.0 bln RUB of feed supplements (+6.4% in monetary terms), 3.7 bln RUB of veterinary drugs (+12.5%), and 0.36 bln RUB of veterinary APIs (+1.6%.)

4/16/2019 Database Update: API Import to Russia (February 2019)

Between January and February 2019, Russia imported 18.9 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms 26% higher than that of the same period in 2018. In physical terms, the dynamics are -7.5% (1.6 tons of APIs.)

All news [150]

Our competences

RNC Pharma is focused on providing information about development trends of Russian pharmaceutical market infrastructure component. Our experts also provide services on strategic marketing, such as forecasting, business planning, etc.